Index by author
March 01, 2005; Volume 16,Issue 3 suppl 1
A
Amann, Kerstin
- You have accessRestricted AccessNephron Number and Renal Risk in Hypertension and DiabetesMarie-Luise Groβ, Kerstin Amann and Eberhard RitzJASN March 2005, 16 (3 suppl 1) S27-S29; DOI: https://doi.org/10.1681/ASN.2004110967
B
Berla, Maya
- You have accessRestricted AccessTreatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up StudyRita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai RavidJASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965
Bilous, Rudy
- You have accessRestricted AccessTargeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal DiseaseMichael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo VibertiJASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973
Bruseghin, Marino
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
C
Campese, Vito M.
- You have accessRestricted AccessAre 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?Vito M. Campese, Mitra K. Nadim and Murray EpsteinJASN March 2005, 16 (3 suppl 1) S11-S17; DOI: https://doi.org/10.1681/ASN.2004110958
Casadevall, Nicole
- You have accessRestricted AccessEpoetin-Induced Autoimmune Pure Red Cell AplasiaNicole Casadevall, Kai-Uwe Eckardt and Jérôme RossertJASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959
Cernigoi, Anna Maria
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
Chiurchiu, Carlos
- You have accessRestricted AccessAngiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-AnalysesCarlos Chiurchiu, Giuseppe Remuzzi and Piero RuggenentiJASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968
Codreanu, Igor
- You have accessRestricted AccessDual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?Igor Codreanu, Norberto Perico and Giuseppe RemuzziJASN March 2005, 16 (3 suppl 1) S34-S38; DOI: https://doi.org/10.1681/ASN.2004110966
D
Dalla Vestra, Michele
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
Deferrari, Giacomo
- You have accessRestricted AccessIntroductionGiacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S1; DOI: https://doi.org/10.1681/ASN.2004110975
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessPrevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity EvaluationMaura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
de Zeeuw, Dick
- You have accessRestricted AccessIndividual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?Liffert Vogt, Gerjan Navis and Dick de ZeeuwJASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074
E
Eckardt, Kai-Uwe
- You have accessRestricted AccessEpoetin-Induced Autoimmune Pure Red Cell AplasiaNicole Casadevall, Kai-Uwe Eckardt and Jérôme RossertJASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959
Epstein, Murray
- You have accessRestricted AccessAre 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?Vito M. Campese, Mitra K. Nadim and Murray EpsteinJASN March 2005, 16 (3 suppl 1) S11-S17; DOI: https://doi.org/10.1681/ASN.2004110958
F
Falqui, Valeria
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Fioretto, Paola
- You have accessRestricted AccessAntihypertensive Treatment and Multifactorial Approach for Renal Protection in DiabetesPaola Fioretto and Anna SoliniJASN March 2005, 16 (3 suppl 1) S18-S21; DOI: https://doi.org/10.1681/ASN.2004110962
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
Frommer-Shapira, Ronni
- You have accessRestricted AccessTreatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up StudyRita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai RavidJASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965
G
Gallina, Pietro
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
García-Donaire, José A.
- You have accessRestricted AccessCalcium Channel Blockers and Renal Protection: Insights from the Latest Clinical TrialsJulián Segura, José A. García-Donaire and Luis M. RuilopeJASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969
Gesualdo, Loreto
- You have accessRestricted AccessPathogenetic Mechanisms of Diabetic NephropathyFrancesco P. Schena and Loreto GesualdoJASN March 2005, 16 (3 suppl 1) S30-S33; DOI: https://doi.org/10.1681/ASN.2004110970
Grassi, Guido
- You have accessRestricted AccessJoint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?Giuseppe Mancia and Guido GrassiJASN March 2005, 16 (3 suppl 1) S74-S77; DOI: https://doi.org/10.1681/ASN.2004110963
Groβ, Marie-Luise
- You have accessRestricted AccessNephron Number and Renal Risk in Hypertension and DiabetesMarie-Luise Groβ, Kerstin Amann and Eberhard RitzJASN March 2005, 16 (3 suppl 1) S27-S29; DOI: https://doi.org/10.1681/ASN.2004110967
K
Karalliedde, Janaka
- You have accessRestricted AccessTargeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal DiseaseMichael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo VibertiJASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973
Krimholtz, Michael J.
- You have accessRestricted AccessTargeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal DiseaseMichael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo VibertiJASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973
L
Leoncini, Giovanna
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
M
Mallamaci, Francesca
- You have accessRestricted AccessInflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate ModelingGiovanni Tripepi, Francesca Mallamaci and Carmine ZoccaliJASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972
Mancia, Giuseppe
- You have accessRestricted AccessJoint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?Giuseppe Mancia and Guido GrassiJASN March 2005, 16 (3 suppl 1) S74-S77; DOI: https://doi.org/10.1681/ASN.2004110963
Morganti, Alberto
- You have accessRestricted AccessShould a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for NoAlberto MorgantiJASN March 2005, 16 (3 suppl 1) S70-S73; DOI: https://doi.org/10.1681/ASN.2004110964
Mussap, Michele
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
N
Nadim, Mitra K.
- You have accessRestricted AccessAre 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?Vito M. Campese, Mitra K. Nadim and Murray EpsteinJASN March 2005, 16 (3 suppl 1) S11-S17; DOI: https://doi.org/10.1681/ASN.2004110958
Navis, Gerjan
- You have accessRestricted AccessIndividual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?Liffert Vogt, Gerjan Navis and Dick de ZeeuwJASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074
P
Parodi, Angelica
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Parodi, Denise
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessPrevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity EvaluationMaura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Perico, Norberto
- You have accessRestricted AccessDual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?Igor Codreanu, Norberto Perico and Giuseppe RemuzziJASN March 2005, 16 (3 suppl 1) S34-S38; DOI: https://doi.org/10.1681/ASN.2004110966
Plebani, Mario
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
Pontremoli, Roberto
- You have accessRestricted AccessIntroductionGiacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S1; DOI: https://doi.org/10.1681/ASN.2004110975
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
R
Rachmani, Rita
- You have accessRestricted AccessTreatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up StudyRita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai RavidJASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965
Ratto, Elena
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessPrevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity EvaluationMaura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Ravera, Maura
- You have accessRestricted AccessPrevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity EvaluationMaura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
Ravid, Mordchai
- You have accessRestricted AccessTreatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up StudyRita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai RavidJASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965
Remuzzi, Giuseppe
- You have accessRestricted AccessDual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?Igor Codreanu, Norberto Perico and Giuseppe RemuzziJASN March 2005, 16 (3 suppl 1) S34-S38; DOI: https://doi.org/10.1681/ASN.2004110966
- You have accessRestricted AccessAngiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-AnalysesCarlos Chiurchiu, Giuseppe Remuzzi and Piero RuggenentiJASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968
Ritz, Eberhard
- You have accessRestricted AccessNephron Number and Renal Risk in Hypertension and DiabetesMarie-Luise Groβ, Kerstin Amann and Eberhard RitzJASN March 2005, 16 (3 suppl 1) S27-S29; DOI: https://doi.org/10.1681/ASN.2004110967
Rossert, Jérôme
- You have accessRestricted AccessEpoetin-Induced Autoimmune Pure Red Cell AplasiaNicole Casadevall, Kai-Uwe Eckardt and Jérôme RossertJASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959
Ruggenenti, Piero
- You have accessRestricted AccessAngiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-AnalysesCarlos Chiurchiu, Giuseppe Remuzzi and Piero RuggenentiJASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968
Ruilope, Luis M.
- You have accessRestricted AccessCalcium Channel Blockers and Renal Protection: Insights from the Latest Clinical TrialsJulián Segura, José A. García-Donaire and Luis M. RuilopeJASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969
S
Saller, Alois
- You have accessRestricted AccessAcute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 DiabetesMichele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola FiorettoJASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
Schächinger, Volker
- You have accessRestricted AccessStem Cells and Cardiovascular and Renal Disease: Today and TomorrowVolker Schächinger and Andreas M. ZeiherJASN March 2005, 16 (3 suppl 1) S2-S6; DOI: https://doi.org/10.1681/ASN.2004110971
Schena, Francesco P.
- You have accessRestricted AccessPathogenetic Mechanisms of Diabetic NephropathyFrancesco P. Schena and Loreto GesualdoJASN March 2005, 16 (3 suppl 1) S30-S33; DOI: https://doi.org/10.1681/ASN.2004110970
Segura, Julián
- You have accessRestricted AccessCalcium Channel Blockers and Renal Protection: Insights from the Latest Clinical TrialsJulián Segura, José A. García-Donaire and Luis M. RuilopeJASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969
Slavacheski, Inna
- You have accessRestricted AccessTreatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up StudyRita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira and Mordchai RavidJASN March 2005, 16 (3 suppl 1) S22-S26; DOI: https://doi.org/10.1681/ASN.2004110965
Solini, Anna
- You have accessRestricted AccessAntihypertensive Treatment and Multifactorial Approach for Renal Protection in DiabetesPaola Fioretto and Anna SoliniJASN March 2005, 16 (3 suppl 1) S18-S21; DOI: https://doi.org/10.1681/ASN.2004110962
T
Thomas, Stephen
- You have accessRestricted AccessTargeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal DiseaseMichael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo VibertiJASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973
Tomolillo, Cinzia
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Tripepi, Giovanni
- You have accessRestricted AccessInflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate ModelingGiovanni Tripepi, Francesca Mallamaci and Carmine ZoccaliJASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972
V
Vaccaro, Valentina
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Vettoretti, Simone
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessPrevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity EvaluationMaura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Viazzi, Francesca
- You have accessRestricted AccessRole of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential HypertensionRoberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto and Giacomo DeferrariJASN March 2005, 16 (3 suppl 1) S39-S41; DOI: https://doi.org/10.1681/ASN.2004110955
- You have accessRestricted AccessImpact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential HypertensionFrancesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto PontremoliJASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
Viberti, Giancarlo
- You have accessRestricted AccessTargeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal DiseaseMichael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous and Giancarlo VibertiJASN March 2005, 16 (3 suppl 1) S42-S47; DOI: https://doi.org/10.1681/ASN.2004110973
Vogt, Liffert
- You have accessRestricted AccessIndividual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?Liffert Vogt, Gerjan Navis and Dick de ZeeuwJASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074
Y
Yale, Jean-François
- You have accessRestricted AccessOral Antihyperglycemic Agents and Renal Disease: New Agents, New ConceptsJean-François YaleJASN March 2005, 16 (3 suppl 1) S7-S10; DOI: https://doi.org/10.1681/ASN.2004110974
Z
Zeiher, Andreas M.
- You have accessRestricted AccessStem Cells and Cardiovascular and Renal Disease: Today and TomorrowVolker Schächinger and Andreas M. ZeiherJASN March 2005, 16 (3 suppl 1) S2-S6; DOI: https://doi.org/10.1681/ASN.2004110971
Zoccali, Carmine
- You have accessRestricted AccessInflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate ModelingGiovanni Tripepi, Francesca Mallamaci and Carmine ZoccaliJASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972